Ketorolac tromethamine is a recent injectable non-steroidal anti-inflammatory drug (NSAID) with analgesic properties approved for short-term pain management. In spite of its increasing use both in adults and children (1-2), relatively few allergic-like reactions have been reported (3–5). Reactions are often severe, and a death occurred following an intramuscular injection of ketorolac (6).
DamenL.BruijnJ.K.VerhagenA.P.BergerM.Y.PasschierJ.KoesB.W., 2005. Symptomatic treatment of migraine in children: A systematic review of medication trials. Pediatrics116:295.
2.
KokkiH.2003. Non-steroidal anti-inflammatory drugs for postoperative pain: A focus on children. Paediatr. Drugs5:103.
3.
ReinhartD.I.2000. Minimising the adverse effects of ketorolac. Drug Saf. 22:487.
4.
GoetzC.M.StercheleJ.A.HarchelroadF.P., 1992. Anaphylactoid reaction following ketorolac tromethamine administration. Ann. Pharmacother.26:1237.
5.
ScalaE.GianiM.PirrottaL.GuerraE.C.LocantoM.De PitàO.PudduP., 2001. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. J. Allergy Clin. Immunol.107:557.
6.
LoganB.K.FrielP.N.PetersonL.K.PredmoreD.B., 1995. Analysis of ketorolac in postmortem blood. J. Anal. Toxicol.19:61.
7.
LeeJ.M.GreenesD.S., 2000. Biphasic anaphylactic reactions in pediatrics. Pediatrics106:762.
8.
DouglasD.M.SukenickE.AndradeW.P.BrownJ.S., 1994. Biphasic systemic anaphylaxis: An inpatient and outpatient study. J. Allergy Clin. Immunol.93:977.
9.
HimlyM.Jhan-SchmidB.PittertschatscherK.BohleB.GrubmayrI.FerreiraF.EbnerH.EbnerC., 2003. IgE-mediated immediate–type hypersensitivity to the pyrazol drug propyphenazone. J. Allergy Clin. Immunol.111:882.